TY - JOUR
T1 - Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice
AU - King, Victoria L.
AU - Trivedi, Darshini B.
AU - Gitlin, Jonathan M.
AU - Loftin, Charles D.
PY - 2006/5
Y1 - 2006/5
N2 - Objective - Inflammation plays an integral role in the development of abdominal aortic aneurysms (AAAs), and the expression of cyclooxygenase (COX)-2 is increased in aneurysmal tissue compared with normal aorta. Nonsteroidal anti-inflammatory drugs, which inhibit the activity of COX-1 and COX-2, decrease AAA expansion in humans and animal models of the disease. In the current study, we investigated the effectiveness of selective inhibition of COX-1 or COX-2 in attenuating AAA formation. Methods and Results - Eight-week-old male apolipoprotein E-deficient mice were treated with selective inhibitors of COX-1 or COX-2, SC-560 (≈25 mg·kg-1·day-1), or celecoxib (≈125 mg·kg-1·day-1), respectively. COX inhibitors were administered 1 week before angiotensin II (Ang II; 1000 ng·kg-1·min-1) or saline infusion and throughout the time course of the experiment. COX-1 inhibition had no effect on incidence (control: 90% [9:10] versus SC-560: 89% [8:9]) or severity of Ang II-induced AAA formation. In contrast, celecoxib decreased the incidence (control: 74% [22:30] versus celecoxib: 11% [2:19]; P<0.001) and severity (P=0.001) of AAA formation. Celecoxib also decreased the incidence and severity of AAAs in nonhyperlipidemic mice. Conclusions - COX-2-derived prostanoids play a fundamental role in the development of Ang II-induced AAAs in both hyperlipidemic and nonhyperlipidemic mice.
AB - Objective - Inflammation plays an integral role in the development of abdominal aortic aneurysms (AAAs), and the expression of cyclooxygenase (COX)-2 is increased in aneurysmal tissue compared with normal aorta. Nonsteroidal anti-inflammatory drugs, which inhibit the activity of COX-1 and COX-2, decrease AAA expansion in humans and animal models of the disease. In the current study, we investigated the effectiveness of selective inhibition of COX-1 or COX-2 in attenuating AAA formation. Methods and Results - Eight-week-old male apolipoprotein E-deficient mice were treated with selective inhibitors of COX-1 or COX-2, SC-560 (≈25 mg·kg-1·day-1), or celecoxib (≈125 mg·kg-1·day-1), respectively. COX inhibitors were administered 1 week before angiotensin II (Ang II; 1000 ng·kg-1·min-1) or saline infusion and throughout the time course of the experiment. COX-1 inhibition had no effect on incidence (control: 90% [9:10] versus SC-560: 89% [8:9]) or severity of Ang II-induced AAA formation. In contrast, celecoxib decreased the incidence (control: 74% [22:30] versus celecoxib: 11% [2:19]; P<0.001) and severity (P=0.001) of AAA formation. Celecoxib also decreased the incidence and severity of AAAs in nonhyperlipidemic mice. Conclusions - COX-2-derived prostanoids play a fundamental role in the development of Ang II-induced AAAs in both hyperlipidemic and nonhyperlipidemic mice.
KW - Abdominal aortic aneurysms
KW - Celecoxib
KW - Cyclooxygenase-1
KW - Cyclooxygenase-2
KW - Prostaglandin E
UR - http://www.scopus.com/inward/record.url?scp=33646462753&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646462753&partnerID=8YFLogxK
U2 - 10.1161/01.ATV.0000216119.79008.ac
DO - 10.1161/01.ATV.0000216119.79008.ac
M3 - Article
C2 - 16514081
AN - SCOPUS:33646462753
SN - 1079-5642
VL - 26
SP - 1137
EP - 1143
JO - Arteriosclerosis, Thrombosis, and Vascular Biology
JF - Arteriosclerosis, Thrombosis, and Vascular Biology
IS - 5
ER -